21st Austria weekly - Fabasoft, EVN, Erste Group, Marinomed (26/02/2021)

EVN: Revenue recorded by utility company EVN rose by 4.8% year-on-year to Euro 604.1 mn in the first quarter of 2020/21. This increase was supported, above all, by the international project business and, in this connection, the wastewater treatment plant project in Kuwait which started in summer 2020. Weather conditions were also reflected in slightly higher network sales in all three core markets. Contrary factors were lower effects from the valuation of hedges for electricity generation and a decline in revenue from natural gas trading. EBITDA recorded by the EVN Group totalled Euro 333.8 mn in the first quarter of 2020/21, which represents an increase of 75.1% over the previous year. Scheduled depreciation and amortisation rose by 18.3% to Euro 84.8 mn, chiefly due to the high level of investment. Group net result for the first quarter of 2020/21 equalled Euro 93.5m, which represents an increase of 12.7% over the previous year.
EVN: weekly performance: -3.12%

Fabasoft: n the first nine months of the 2020/2021 fiscal year the IT company Fabasoft recorded sales revenue of Euro 42.07 mn (36.18 mn in the corresponding period of the previous year). With EBITDA at 15.985 mn (11.104 mn in the corresponding period of the previous year) EBIT was Euro 11.775 mn (7.36 mn in the corresponding period of the previous year). According to the company, these figures reflect an increase in the recurring revenue from software and services, an extremely strong project business field, as well as high licence revenue from one-off licences. These licence revenue from one-off licences in particular do not follow any regular pattern and are subject to very sharp quarterly fluctuations. Potential new customers showed a keen interest in digitisation topics, but also a marked reticence and wariness, es- pecially where high-volume contracts are concerned.
Fabasoft: weekly performance: -5.00%

Erste Group: Erste Group posts net profit of Euro 783.1 mn in 2020, down from Euro 1.47 bn in 2019. Net interest income increased – mainly in Austria, but also in Romania and Hungary – to Euro 4,774.8 mn (+0.6%; Euro 4,746.8 mn). Net fee and commission income decreased to Euro 1,976.8 mn (-1.2%; Euro 2,000.1 min). Higher income from the securities business and asset management did not fully compensate for the declines in other fee and commission income categories – most notably in payment services (thereof Euro 19 mn attributable to the impact of the SEPA Payment Services Directive). While net trading result declined significantly to Euro 137.6 mn (Euro 318.3 mn), the line item gains/losses from financial in- struments measured at fair value through profit or loss improved to Euro 62.0 mn (EUR -24.5 million).  Operating income decreased to Euro 7,155.1 mn (-1.4%; Euro 7,255.9 mn). Overall, the operating result declined to Euro 2,934.6 mn (-1.3%; Euro 2,972.7 mn). The cost/income ratio was unchanged at 59.0% (59.0%).
Erste Group: weekly performance: 3.33%

Marinomed: Marinomed Biotech AG, a globally operating biopharmaceutical company, announced today that the Company ranks in the first place on Boston Consulting Group’s (BCG) Gender Diversity Index Austria 2020 and is officially Austria’s most diverse company regarding gender composition of corporate boards. The study focused on the 50 largest public companies in Austria by market capitalization. Marinomed received 83.4 points out of the 100 points available, which are assigned to an equal distribution of men and women in (supervisory) board positions as well as equal average pay for men and women. In contrast, the 50 Austrian companies received only 33 points in average. 
Marinomed Biotech: weekly performance: -12.86%